How to use the speech recognition tool?
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy (LHON).
Status of the trial: Completed
Orphan Drug Recognition: NA
- Opening Date: 2016-09-01
- Closing Date: 2021-02-01
Inclusion: Patient prescribed Raxone® for the treatment of LHON; Patient has completed an Informed Consent Form (ICF) indicating that he/ she (or a legally acceptable representative) has been informed of all pertinent aspects of the study and has agreed to participa
Exclusion: No explicit exclusion criteria exist to avoid selection bias and to allow for documentation of routine clinical practice.
Funder Type: industry
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
- Neuro-Ophthalmology Rare Diseases (WG2)
This ERN is supported by: